| Document and Entity Information - shares | 3 Months Ended | |
| Oct. 31, 2018 | Dec. 21, 2018 | |
| Equity Issuance Dollar Amount Per Share Duration One | ||
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Document Period End Date | Oct. 31, 2018 | |
| Entity Registrant Name | Hartford Great Health Corp. | |
| Entity Central Index Key | 1,482,554 | |
| Current Fiscal Year End Date | --07-31 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2,019 | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Emerging Growth Company | true | |
| Entity Small Business | true | |
| Entity Ex Transition Period | false | |
| Entity Common Stock, Shares Outstanding | 99,108,000 | |
| Is Entity's Reporting Status Current? | Yes |
| CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) | Oct. 31, 2018 | Jul. 31, 2018 |
| Current assets: | ||
| Cash and cash equivalents | $ 26,768 | $ 1,444 |
| Total current assets | 26,768 | 1,444 |
| Property and Equipment | ||
| Office equipment | 0 | 2,792 |
| Less - Accumulated depreciation | 0 | (2,792) |
| Total Property and Equipment | 0 | 0 |
| Total assets | 26,768 | 1,444 |
| Current liabilities: | ||
| Accounts payable | 1,335 | 832 |
| Loan from related party | 30,000 | 0 |
| Total current liabilities | 31,335 | 832 |
| Total liabilities | 31,335 | 832 |
| Stockholders' equity (deficit): | ||
| Preferred stock - $0.001 par value, 5,000,000 shares authorized: No shares issued or outstanding | 0 | 0 |
| Common stock - $0.001 par value, 100,000,000 shares authorized: 3,018,000 shares issued and outstanding | 3,018 | 3,018 |
| Additional paid-in capital | 328,811 | 330,241 |
| Accumulated (deficit) | (336,396) | (332,647) |
| Total stockholders' deficit | (4,567) | 612 |
| Total liabilities and stockholders' deficit | $ 26,768 | $ 1,444 |
| CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares | Oct. 31, 2018 | Jul. 31, 2018 |
| Statement of Financial Position [Abstract] | ||
| Preferred stock, par value per share | $ 0.001 | $ 0.001 |
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value per share | $ 0.001 | $ 0.001 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 3,018,000 | 3,018,000 |
| Common stock, shares outstanding | 3,018,000 | 3,018,000 |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
| Oct. 31, 2018 | Oct. 31, 2017 | |
| Income Statement [Abstract] | ||
| Revenues | $ 0 | $ 0 |
| Operating expenses: | ||
| Website development | 0 | 177 |
| Legal and accounting fees | 935 | 788 |
| Investor relations | 2,783 | 300 |
| Other general and administrative | 31 | 77 |
| Depreciation Expense | 0 | 235 |
| Total operating expenses | 3,749 | 1,577 |
| Operating (loss) | (3,749) | (1,577) |
| Other income(expense): | ||
| Interest expense | 0 | (106) |
| Other income (expense) net | 0 | (106) |
| Net (loss) | $ (3,749) | $ (1,683) |
| Net (loss) per common share: Basic and Diluted | $ (0.01) | $ (0.01) |
| Weighted average shares outstanding: Basic and Diluted | 3,018,000 | 3,018,000 |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
| Oct. 31, 2018 | Oct. 31, 2017 | |
| Cash flows from operating activities: | ||
| Net (loss) | $ (3,749) | $ (1,683) |
| Adjustments to reconcile net (loss) to net cash used by operating activities: | ||
| Depreciation | 0 | 235 |
| Changes in operating assets and liabilities: | ||
| Increase/(decrease) in accounts payable | 502 | (572) |
| Increase/(decrease) in interest payable | 0 | 106 |
| Net cash (used in) operating activities | (3,247) | (1,914) |
| Cash flows from financing activities: | ||
| Loans from stockholders | 30,000 | 2,700 |
| Return of capital | (1,429) | 0 |
| Net cash provided by financing activities | 28,571 | 2,700 |
| Net increase (decrease) in cash and equivalents | 25,324 | 786 |
| Cash and equivalents at beginning of period | 1,444 | 1,928 |
| Cash and equivalents at end of period | 26,768 | 2,714 |
| Supplemental Cash Flow Information | ||
| Interest paid | 0 | 0 |
| Income taxes paid | $ 0 | $ 0 |
| Nature of Operations and Summary of Significant Accounting Policies | 3 Months Ended |
| Oct. 31, 2018 | |
| Accounting Policies [Abstract] | |
| Nature of Operations and Summary of Significant Accounting Policies | 1. Nature of Operations and Summary of Significant Accounting Policies Nature of Operations Hartford Great Health Corp. ("the Company" formerly "PhotoAmigo, Inc." organized under the laws of Nevada on April 2, 2008) is now certified and complies with the requirements of California law effective on September 6, 2018, for the purpose of qualifying to transact intrastate business in the State of California. It plans to develop the Sino-US Health industry. In January 2019, the two subsidiaries in Hangzhou and Shanghai, China, will start marketing programs to promote the sales of US health products as well as artificial intelligence products related to the health and wellness industry. Summary of Significant Accounting Policies Interim Financial Information: Use of Estimates: Cash and Cash Equivalents: Income Taxes: Revenue Recognition: Income (Loss) Per Share: Recent Accounting Pronouncements: |
| Going Concern | 3 Months Ended |
| Oct. 31, 2018 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Going Concern | 2. Going Concern The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, Hartford Great Health Corp. has incurred losses since inception (April 2, 2008), resulting in an accumulated deficit of $336,396 as of October 31, 2018. These conditions raise substantial doubt about the ability of Hartford Great Health Corp. to continue as a going concern. In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to Hartford Great Health Corp., and ultimately achieving profitable operations. Management cannot provide assurance that Hartford Great Health Corp. will meet its objectives and be able to continue in operation. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of Hartford Great Health Corp. to continue as a going concern. |
| Related Party Transactions | 3 Months Ended |
| Oct. 31, 2018 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | 3. Related Party Transactions During the three months ended October 31, 2018, the Company borrowed $30,000 from a potential investor to fund the Company's ongoing activities. It is an indefinite short-term loan with no interest. The potential investor has not received any equity for this loan and this loan is repayable by the Company. During the first three months of 2017, the company borrowed $2,700 from two shareholders: $2,500 from one and $200 from the other shareholder. During the same time frame in 2017 the Company accrued an interest expense of $106 for the three months of 2017. During the first quarter of 2018 the company also refunded $1,429 of the additional paid in capital to the former CFO. Office space is provided to Hartford Great Health Corp. at no additional cost by the executive officers. No provision for these costs has been included in these financial statements as the amounts are not material. |
| Stockholders' Equity | 3 Months Ended |
| Oct. 31, 2018 | |
| Stockholders' equity (deficit): | |
| Stockholders' Equity | 4. Stockholders' Equity Preferred Stock The Company is authorized to issue 5,000,000 shares of preferred stock with a par value of $0.001 per share. No shares of preferred stock have been issued or outstanding since Inception (April 2, 2008). Common Stock The Company is authorized to issue 100,000,000 shares or common stock with a par value of $0.001 per share. No shares of common stock were issued during the three months ended October 31, 2018 or 2017. |
| Subsequent Events | 3 Months Ended |
| Oct. 31, 2018 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | 5. Subsequent Events In accordance with ASC 855 , "Subsequent Events" The Hangzhou subsidiary received their business license from the Chinese Business Administrative Authority on October 22, 2018. The office space is currently being setup. This subsidiary will not commence operations until January of 2019. The Shanghai subsidiary has also not commenced operations as the business license is being processed. The company issued an additional 96,090,000 shares of common stock on December 11 th |
| Nature of Operations and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
| Oct. 31, 2018 | |
| Accounting Policies [Abstract] | |
| Interim Financial Information | Interim Financial Information: |
| Use of Estimates | Use of Estimates: |
| Cash and Cash Equivalents | Cash and Cash Equivalents: |
| Income Taxes | Income Taxes: |
| Revenue Recognition | Revenue Recognition: |
| Income (Loss) Per Share | Income (Loss) Per Share: |
| Recent Accounting pronouncements | Recent Accounting Pronouncements: |
| Going Concern (Details Narrative) - USD ($) | Oct. 31, 2018 | Jul. 31, 2018 |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Accumulated deficit | $ (336,396) | $ (332,647) |
| Related Party Transactions (Details Narrative) - USD ($) | 3 Months Ended | |
| Oct. 31, 2018 | Oct. 31, 2017 | |
| Accrued interest expense | $ 106 | |
| Additional paid in capital refunded | $ 1,429 | 0 |
| Investor [Member] | ||
| Amount borrowed | 30,000 | |
| Two shareholders [Member] | ||
| Amount borrowed | 2,700 | |
| One shareholders [Member] | ||
| Amount borrowed | 2,500 | |
| Other shareholders [Member] | ||
| Amount borrowed | $ 200 | |
| Chief Financial Officer [Member] | ||
| Additional paid in capital refunded | $ 1,429 | |
| Stockholders' Equity (Details Narrative) - $ / shares | Oct. 31, 2018 | Jul. 31, 2018 |
| Stockholders' equity (deficit): | ||
| Preferred stock, par value per share | $ 0.001 | $ 0.001 |
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value per share | $ 0.001 | $ 0.001 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Subsequent Events (Details Narrative) - USD ($) | Dec. 11, 2018 | Dec. 21, 2018 | Oct. 31, 2018 | Jul. 31, 2018 |
| Common stock, shares outstanding | 3,018,000 | 3,018,000 | ||
| Subsequent Event [Member] | ||||
| Stock issued during the period, Shares | 96,090,000 | |||
| Stock issued during the period, value | $ 1,921,800 | |||
| Common stock, shares outstanding | 99,108,000 |
